Description
The authors mention that MEF2A and pFoxO3 factors are dysregulated in ALS and modulated by their treatment, but don’t explain the mechanistic connection between enhanced neurogenesis and ALS therapeutic benefit. This gap is critical for understanding whether neurogenesis enhancement addresses ALS motor neuron loss or other disease aspects.
Gap type: open_question Source paper: Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling. (2021, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, PMID:33860461)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:40.585683+00:00”, “resolution_summary”: “Resolved by hypothesis h-alsmnd-e448328ae294: GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons. Supporting evidence includes debate sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-alsmnd-e448328ae294”, “title”: “GLE1-Mediated mRNA Export Defect Creates Translation-Competent mRNA Starvation in ALS Motor Neuron Axons”, “score”: 0.256, “reason”: “11 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “GLE1,DBP10,EXPORTIN-1,XPO1,mRNA export machinery,NPC”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.822847, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“25343993”, “26776475”, “26921650”, “34025336”]}, {“id”: “ec8b839c-6440-45dc-aff6-5edea1fd2d6d”, “title”: “STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker of TDP-43 Nuclear Depletion in ALS Motor Neurons”, “score”: 0.237, “reason”: “6 token overlaps; entity overlap: als”, “analysis_id”: “0ed3c364-07fd-4620-8e90-8bd33c14e370”, “target_gene”: “TARDBP”, “target_pathway”: “TDP-43 splicing regulation / axon maintenance”, “disease”: “ALS”, “composite_score”: 0.720856, “confidence_score”: 0.6, “status”: “open”, “pubmed_evidence_ids”: [“30643292”, “34879411”, “34930382”, “36927019”, “38967083”]}, {“id”: “h-alsmnd-006d646506ab”, “title”: “hnRNP A2/B1 Staufen2-Mediated Axonal RNA Granule Transport Failure Drives Distal Axon Degeneration in ALS”, “score”: 0.236, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “HNRNPA2B1,STAU2,PRMT1,GSK3B,MAP1B,β-actin,axonal transport machinery”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.851136, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“30344044”, “34290090”, “40737092”, “41044342”]}, {“id”: “h-alsmnd-01446b71d93f”, “title”: “MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs and Triggers Splicing Defects in ALS Motor Neurons”, “score”: 0.233, “reason”: “9 token overlaps; entity overlap: als”, “analysis_id”: null, “target_gene”: “MATR3,U1 snRNP,SNRPB,SNRNP70, splicing machinery,spliceosome”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.801172, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“20301623”, “24686783”, “30157547”, “35205163”, “38891112”]}, {“id”: “h-72c719461c”, “title”: “C9orf72 ASO Treatment Reverses TDP-43 Pathology in ALS/FTD”, “score”: 0.224, “reason”: “5 token overlaps; entity overlap: als”, “analysis_id”: “test-hypothesis-fixtures-v1”, “target_gene”: “C9orf72”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.72, “confidence_score”: 0.88, “status”: “proposed”, “pubmed_evidence_ids”: [“21944792”, “28960178”, “29460270”, “39605053”, “40520109”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5”, “title”: “While ALS-causing mutations impair autophagy factors, the neuron-specific effects remain incompletely defined according to the authors. This knowledge gap prevents precise understanding of selective neuronal vulnerability in ALS.\n\nGap type: open_question\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.553, “reason”: “12 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd”, “quality_score”: 0.812, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.51, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.509, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.492, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-041423-3a6aa4ab_task_9aae8fc5”, “title”: “The study shows TRIM21 and autophagy receptors can eliminate both physiological and pathological SGs, yet persistent stress granules are hallmarks of ALS/FTD. The mechanisms by which disease-associated SGs evade this clearance system remain unclear but are critical for therapeutic targeting.\n\nGap type: open_question\nSource paper: Stress granule homeostasis is modulated by TRIM21-mediated ubiquitination of G3BP1 and autophagy-dependent elimination of stress granules. (2023, Autophagy, PMID:36692217)”, “score”: 0.475, “reason”: “10 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-041423-3a6aa4ab”, “quality_score”: 0.746, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}